Courtesy of Benzinga.
Natural Alternatives International (NASDAQ: NAII) announced today that on December 21 it sued Woodbolt Distribution, LLC, also known as Cellucor, Vitaquest International, Inc., d/b/a Garden State Nutritionals and F.H.G. Corporation, d/b/a Integrity Nutraceuticals in the U.S. District Court for the Southern District of Texas, Houston Division, Civil Action No: 4:11-cv-04511, for infringing U.S. Patent No. 8,067,381, entitled “Methods and compositions for increasing the anaerobic working capacity in tissues.” The patent is part of NAI’s worldwide portfolio covering CarnoSyn® beta-alanine.
NAI filed the complaint in federal court after Woodbolt failed to comply with a cease and desist demand. The complaint alleges that Woodbolt sells nutritional supplements, including supplements containing beta-alanine such as C4 Extreme™, M5 Extreme™, and N-Zero Extreme™ that infringe the ‘381 patent. NAI alleges that Woodbolt itself represents to the public that the products contain beta-alanine. NAI also sued Woodbolt’s alleged contract manufacturers, Garden State and Integrity for infringing NAI’s patent.
For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.
